{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SLDB/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T19:44:40.904Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4225,"canonical_name":"Solid Biosciences Inc.","cik":"0001707502","uei":null,"lei":null,"duns":null,"ticker":"SLDB"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":18,"clinical":4},"count":22,"timeline":[{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Solid Biosciences Inc. — 2026-08-14","url_slug":"/sec/cik-0001707502/schedule-13g-a/0000902664-26-003502","accession_number":"0000902664-26-003502","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Solid Biosciences Inc. — 2026-08-06","url_slug":"/sec/cik-0001707502/schedule-13g/0000315066-26-002128","accession_number":"0000315066-26-002128","importance":55},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Solid Biosciences Inc. — 2026-08-06","url_slug":"/sec/cik-0001707502/10-q/0001193125-26-337935","accession_number":"0001193125-26-337935","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Solid Biosciences Inc. — 2026-08-06","url_slug":"/sec/cik-0001707502/8-k/0001193125-26-338438","accession_number":"0001193125-26-338438","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"424B5","title":"424B5 — Solid Biosciences Inc. — 2026-08-06","url_slug":"/sec/cik-0001707502/424b5/0001193125-26-338410","accession_number":"0001193125-26-338410","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"S-3ASR","title":"S-3ASR — Solid Biosciences Inc. — 2026-08-06","url_slug":"/sec/cik-0001707502/s-3asr/0001193125-26-338387","accession_number":"0001193125-26-338387","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Solid Biosciences Inc. — 2026-07-30","url_slug":"/sec/cik-0001707502/schedule-13g/0002012383-26-003093","accession_number":"0002012383-26-003093","importance":55},{"ts":"2026-07-02","kind":"sec.insider.m","reporter":"SMITH IAN F","title":null,"shares":3440,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-24","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — RA CAPITAL MANAGEMENT, L.P. — 2026-06-24","url_slug":"/sec/cik-0001346824/schedule-13d-a/0001346824-26-000183","accession_number":"0001346824-26-000183","importance":70},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Solid Biosciences Inc. — 2026-06-11","url_slug":"/sec/cik-0001707502/4/0001193125-26-267502","accession_number":"0001193125-26-267502","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Solid Biosciences Inc. — 2026-06-11","url_slug":"/sec/cik-0001707502/4/0001193125-26-267489","accession_number":"0001193125-26-267489","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Solid Biosciences Inc. — 2026-06-11","url_slug":"/sec/cik-0001707502/4/0001193125-26-267494","accession_number":"0001193125-26-267494","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Solid Biosciences Inc. — 2026-06-11","url_slug":"/sec/cik-0001707502/4/0001193125-26-267496","accession_number":"0001193125-26-267496","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Solid Biosciences Inc. — 2026-06-11","url_slug":"/sec/cik-0001707502/4/0001193125-26-267500","accession_number":"0001193125-26-267500","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Solid Biosciences Inc. — 2026-06-10","url_slug":"/sec/cik-0001707502/8-k/0001193125-26-265804","accession_number":"0001193125-26-265804","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"424B7","title":"424B7 — Solid Biosciences Inc. — 2026-06-05","url_slug":"/sec/cik-0001707502/424b7/0001193125-26-259503","accession_number":"0001193125-26-259503","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Solid Biosciences Inc. — 2026-05-12","url_slug":"/sec/cik-0001707502/10-q/0001193125-26-219337","accession_number":"0001193125-26-219337","importance":45},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Solid Biosciences Inc.","title":"A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07160634","excerpt":"[\"Duchenne Muscular Dystrophy\"]","importance":60},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Solid Biosciences Inc.","title":"A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)","security_title":"PHASE1,PHASE2","status":"RECRUITING","accession_number":"NCT06138639","excerpt":"[\"Duchenne Muscular Dystrophy\"]","importance":45},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Solid Biosciences Inc.","title":"Microdystrophin Gene Transfer Study in Adolescents and Children With DMD","security_title":"PHASE1,PHASE2","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT03368742","excerpt":"[\"Duchenne Muscular Dystrophy\"]","importance":45},{"ts":"2026-04-27","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Solid Biosciences Inc. — 2026-04-27","url_slug":"/sec/cik-0001707502/schedule-13g-a/0002012383-26-001720","accession_number":"0002012383-26-001720","importance":30},{"ts":"2026-04-27","kind":"clinical.trial","reporter":"Solid Biosciences Inc.","title":"A Study of SGT-212 Gene Therapy in Friedreich's Ataxia","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07180355","excerpt":"[\"Friedreich's Ataxia (FA)\"]","importance":30}]}